Freedonia Focus on Transdermal & Implantable Drug Delivery Systems

This report discusses US implantable and transdermal drug delivery systems for the years 2002 and 2007, with forecasts for 2012. Topics covered include market size, product and end-use segmentation, technology and product development, market environment, product and end-use forecasts, industry composition and leading participants. Product segments cover implantable systems (including drug-eluting coronary stents and other implantable systems) and transdermal patches (including central nervous system [CNS] patches and other transdermal patches). End-use applications include cardiovascular agents, central nervous system [CNS] agents, hormones and related agents, and other agents. This 20 page report also includes a highlights summary and a resources section.